Medical News

RSS

Diagnostic Nano Technology to use Instant Detect Technology to detect H1N1 virus

Diagnostic Nano Technology Corporation (DNA), a subsidiary of Avisio, Inc., announced today that with the early laboratory success of its Instant Detect Technology in the detection of certain viruses that cause Dengue Fever, it plans to begin testing the technology on the detection of the H1N1 virus.

17 Dec 2009

Communication strategies can benefit dementia patients and caregivers

Alzheimer's disease and other forms of dementia represent an exponentially growing social and health care challenge for American families - not only family members who face the progressive brain disease, but also those who love them.

17 Dec 2009

FDA Advisory Committee votes against the approval of Tarceva

OSI Pharmaceuticals, Inc. and Genentech, Inc., a wholly owned member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) voted 12 to one recommending against approval of the daily pill Tarceva® (erlotinib) for first-line maintenance use in people with advanced or metastatic non-small cell lung cancer (NSCLC) whose cancer has not progressed (grown or spread) following first-line treatment with platinum-based chemotherapy.

17 Dec 2009

Silence Therapeutics and Intradigm merge to form RNAi

The Boards of Silence Therapeutics plc and Intradigm Corporation are delighted to announce the merger of their businesses to form a leading company in the field of RNAi (RNA interference).

17 Dec 2009

USANA Health Sciences announces partnership with Utah Grizzlies

USANA Health Sciences, Inc. is proud to announce its partnership with the Utah Grizzlies as the team’s official nutritional supplement provider.

17 Dec 2009

MRG: Chinese drug-eluting stent market to reach more than $900 million by 2014

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, health care reforms in China supported rapid expansion of the Chinese drug-eluting stent market in 2009, and will continue to fuel growth in the coming years.

17 Dec 2009

St. Jude Medical applauds the updated level of evidence for FFR-guided treatment

St. Jude Medical, Inc. applauds the updated level of evidence for Fractional Flow Reserve (FFR)-guided treatment in the Guidelines on Percutaneous Coronary Intervention (PCI).

17 Dec 2009

New study shows families, not doctors, raise the issue of prayer

What happens when the families of sick and dying hospitalized children ask their physicians to pray with them, or for them? How do pediatricians respond to such personal requests? While increasing numbers of physicians say that religion and spirituality help some patients and families cope with serious illness, a new study reports that it is almost always the families and patients who raise the issue of prayer, not the doctors themselves.

17 Dec 2009

Proposed health care legislation to set new standards in employer-based insurance system

If proposed health care legislation is enacted, it would set new standards in the employer-based insurance system. Approximately 18.4 million Californians and 161 million Americans under the age of 65 rely upon employer-based insurance for their health care coverage.

17 Dec 2009

Californian children’s health shows consistent improvement, but recession can undermine gains

A newly created index measuring the overall health and well-being of California’s children and youth shows a consistent pattern of improvement over the last decade, but researchers warn that the present economic recession could undermine and possibly even reverse those gains.

17 Dec 2009

New security solution that integrates palm vein biometric technology introduced

IBM (IBM) and Fujitsu Frontech North America Inc. today announced a new security solution that integrates palm vein biometric technology from Fujitsu with IBM's leading enterprise single sign-on solution.

17 Dec 2009

New learning collaborative for healthcare organizations

HealthSciences Institute will sponsor a new learning collaborative for health care professionals, teams and organizations who serve individuals at risk of, or affected by, chronic diseases in employer, health plan, medical home and other provider settings.

17 Dec 2009

AAD's National Melanoma/Skin Cancer Screening Program reaches milestone

One person dies from melanoma, the deadliest form of skin cancer, almost every hour. Yet melanoma is often successfully treated, if caught early. That's why thousands of dermatologists across the country offer free skin cancer screenings in their communities through the American Academy of Dermatology's (AAD) National Melanoma/Skin Cancer Screening Program.

17 Dec 2009

ARNMD meeting examines psychological and neurological aspects of PTSDs and traumatic brain injuries

War is hell, as the old saying goes -- with loss of life and limb, destruction of infrastructure and the environment, and devastating costs. Recent biomedical research has shed light on another pernicious consequence of military conflict: psychological and neurological conditions like post-traumatic stress disorder and traumatic brain injury. At the same time, researchers have worked to uncover some of the motives and meanings of war.

17 Dec 2009

ODAC to review Cell Therapeutics' NDA for pixantrone

Cell Therapeutics, Inc. (CTI) announced today that on February 10, 2010 the U.S. Food and Drug Administration's Oncologic Drugs Advisory Committee (ODAC) will review the New Drug Application (NDA) for pixantrone for the treatment of relapsed/refractory aggressive non-Hodgkin's lymphoma (NHL).

17 Dec 2009

CIHR experts offer suggestions for stress-free holiday

The holiday season is synonymous with joy, family and sharing, but it can also mean anxiety, melancholy and illness. With the recent economic downturn and the H1N1 pandemic, many Canadians are facing higher stress levels, sleepless nights and health problems.

17 Dec 2009

ODAC to conduct public advisory meeting to review ChemGenex Pharmaceuticals’ NDA for Omapro

ChemGenex Pharmaceuticals Limited announced today the U.S. Food and Drug Administration (FDA) has notified the company that the Oncologic Drugs Advisory Committee (ODAC) will conduct a public advisory meeting on 10 February 2010 to review the Company’s NDA for Omapro™ (omacetaxine mepesuccinate) for injection.

17 Dec 2009

HFU increases mortality among diabetics, says report

Cardium Therapeutics today reported on recent clinical findings published in the December issue of Diabetes Care showing an increase in mortality in diabetic patients with a history of foot ulcer (HFU) compared with diabetic patients without HFU and with non-diabetic patients.

17 Dec 2009

Smart Balance announces $25 million stock repurchase program

Smart Balance, Inc. announced today that its board of directors has authorized a two-year stock repurchase program of up to $25 million, to begin in 2010.

17 Dec 2009

Transcend Services announces pricing of common stock

Transcend Services, Inc. today announced today announced that the public offering of 2,220,000 shares of its common stock has priced at $16.75 per share.

17 Dec 2009